nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An approach to p32/gC1qR/HABP1: a multifunctional protein with an essential role in cancer
|
Egusquiza-Alvarez, Carlos Alejandro |
|
|
148 |
8 |
p. 1831-1854 |
artikel |
2 |
A retrospective analysis using deep-learning models for prediction of survival outcome and benefit of adjuvant chemotherapy in stage II/III colorectal cancer
|
Li, Xingyu |
|
|
148 |
8 |
p. 1955-1963 |
artikel |
3 |
Blimp-1 is a prognostic indicator for progression of cervical intraepithelial neoplasia grade 2
|
Saito, Mayumi |
|
|
148 |
8 |
p. 1991-2002 |
artikel |
4 |
CDH1 germline mutations in a Chinese cohort with hereditary diffuse gastric cancer
|
Pan, Zhiwen |
|
|
148 |
8 |
p. 2145-2151 |
artikel |
5 |
Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML)
|
Demircan, Muhammed Burak |
|
|
148 |
8 |
p. 1983-1990 |
artikel |
6 |
Correction: Investigation of the protective effect of gel incorporating Eugenia jambolana leaf extract on 5-fluorouracil-induced oral mucositis: an animal study
|
Aksoy, Nilay |
|
|
148 |
8 |
p. 2163 |
artikel |
7 |
Diet and gastric cancer risk: an umbrella review of systematic reviews and meta-analyses of prospective cohort studies
|
Liu, Shu-Jun |
|
|
148 |
8 |
p. 1855-1868 |
artikel |
8 |
Effect of antimicrobial therapy on progression-free survival of patients with non-small cell lung cancer receiving checkpoint inhibitor- and chemotherapy
|
Uhlenbruch, Mark |
|
|
148 |
8 |
p. 2079-2082 |
artikel |
9 |
Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer
|
Myer, Nicole M. |
|
|
148 |
8 |
p. 2023-2043 |
artikel |
10 |
Expression and clinical prognostic value of CYB561 in breast cancer
|
Zhou, Xiaofeng |
|
|
148 |
8 |
p. 1879-1892 |
artikel |
11 |
First and repeat rebiopsy for detecting EGFR T790M mutation in non-small-cell lung cancer: CS-Lung-003 prospective observational registry study
|
Kudo, Kenichiro |
|
|
148 |
8 |
p. 1869-1877 |
artikel |
12 |
Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy
|
Maitre, Elsa |
|
|
148 |
8 |
p. 2013-2022 |
artikel |
13 |
Immunological and nutritional predictive factors in patients receiving pembrolizumab for the first-line treatment of non-small cell lung cancer
|
Shijubou, Naoki |
|
|
148 |
8 |
p. 1893-1901 |
artikel |
14 |
Improved outcome in children compared to adolescents and young adults after allogeneic hematopoietic stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC)
|
Pochon, Cécile |
|
|
148 |
8 |
p. 2083-2097 |
artikel |
15 |
Individualized clinical target volume delineation and efficacy analysis in unilateral nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT): 10-year summary
|
Xie, De-Huan |
|
|
148 |
8 |
p. 1931-1942 |
artikel |
16 |
Investigation of the protective effect of gel incorporating Eugenia jambolana leaf extract on 5-fluorouracil-induced oral mucositis: an animal study
|
Aksoy, Nilay |
|
|
148 |
8 |
p. 2153-2162 |
artikel |
17 |
iRECIST-based versus non-standardized free text reporting of CT scans for monitoring metastatic renal cell carcinoma: a retrospective comparison
|
Schomburg, Laura |
|
|
148 |
8 |
p. 2003-2012 |
artikel |
18 |
Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study
|
Chen, Song |
|
|
148 |
8 |
p. 2115-2125 |
artikel |
19 |
miR-144 inhibits the IGF1R-ERK1/2 signaling pathway via NUDCD1 to suppress the proliferation and metastasis of colorectal cancer cells: a study based on bioinformatics and in vitro and in vivo verification
|
Han, Bin |
|
|
148 |
8 |
p. 1903-1918 |
artikel |
20 |
Molecular diagnostics and therapies for gastrointestinal tumors: a real-world experience
|
Welland, Sabrina |
|
|
148 |
8 |
p. 2137-2144 |
artikel |
21 |
Quality of life in lung cancer survivors treated with tyrosine-kinase inhibitors (TKI): results from the multi-centre cross-sectional German study LARIS
|
Riccetti, Nicola |
|
|
148 |
8 |
p. 1943-1953 |
artikel |
22 |
Radiotherapy for glioblastoma patients with poor performance status
|
Schröder, Christina |
|
|
148 |
8 |
p. 2127-2136 |
artikel |
23 |
Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation
|
Luo, Yung-Hung |
|
|
148 |
8 |
p. 2099-2114 |
artikel |
24 |
Regulatory network identified by pulmonary transcriptome and proteome profiling reveals extensive change of tumor-related genes in microRNA-21 knockout mice
|
Luan, Ge |
|
|
148 |
8 |
p. 1919-1929 |
artikel |
25 |
Role of ANO1 in tumors and tumor immunity
|
Li, Haini |
|
|
148 |
8 |
p. 2045-2068 |
artikel |
26 |
Role of the alpha-fetoprotein response in immune checkpoint inhibitor-based treatment of patients with hepatocellular carcinoma
|
Kim, Ha Il |
|
|
148 |
8 |
p. 2069-2077 |
artikel |
27 |
Transformation of invasive lung adenocarcinoma with ALK rearrangement into pulmonary sarcomatoid carcinoma
|
Xie, Xianjin |
|
|
148 |
8 |
p. 2165-2168 |
artikel |
28 |
Upregulated LINC01088 facilitates malignant phenotypes and immune escape of colorectal cancer by regulating microRNAs/G3BP1/PD-L1 axis
|
Li, Chenmeng |
|
|
148 |
8 |
p. 1965-1982 |
artikel |